NL8500181A - Voor gebruik gereed vloeibaar reagens ter bepaling van het glucosegehalte in bloed. - Google Patents
Voor gebruik gereed vloeibaar reagens ter bepaling van het glucosegehalte in bloed. Download PDFInfo
- Publication number
- NL8500181A NL8500181A NL8500181A NL8500181A NL8500181A NL 8500181 A NL8500181 A NL 8500181A NL 8500181 A NL8500181 A NL 8500181A NL 8500181 A NL8500181 A NL 8500181A NL 8500181 A NL8500181 A NL 8500181A
- Authority
- NL
- Netherlands
- Prior art keywords
- ready
- determining
- reagent
- use liquid
- blood
- Prior art date
Links
- 239000003153 chemical reaction reagent Substances 0.000 title claims description 34
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 title claims description 16
- 239000008103 glucose Substances 0.000 title claims description 16
- 239000008280 blood Substances 0.000 title claims description 13
- 210000004369 blood Anatomy 0.000 title claims description 13
- 239000007788 liquid Substances 0.000 title claims description 11
- 239000004366 Glucose oxidase Substances 0.000 claims description 13
- 108010015776 Glucose oxidase Proteins 0.000 claims description 13
- 229940116332 glucose oxidase Drugs 0.000 claims description 13
- 235000019420 glucose oxidase Nutrition 0.000 claims description 13
- 238000000034 method Methods 0.000 claims description 10
- 229920003171 Poly (ethylene oxide) Polymers 0.000 claims description 7
- 239000002736 nonionic surfactant Substances 0.000 claims description 7
- 239000004094 surface-active agent Substances 0.000 claims description 7
- -1 polyoxyethylene Polymers 0.000 claims description 6
- 239000003381 stabilizer Substances 0.000 claims description 3
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 10
- RLFWWDJHLFCNIJ-UHFFFAOYSA-N 4-aminoantipyrine Chemical compound CN1C(C)=C(N)C(=O)N1C1=CC=CC=C1 RLFWWDJHLFCNIJ-UHFFFAOYSA-N 0.000 description 8
- 239000000203 mixture Substances 0.000 description 8
- 238000006243 chemical reaction Methods 0.000 description 6
- 230000002255 enzymatic effect Effects 0.000 description 6
- 102000004190 Enzymes Human genes 0.000 description 5
- 108090000790 Enzymes Proteins 0.000 description 5
- ISWSIDIOOBJBQZ-UHFFFAOYSA-N Phenol Chemical compound OC1=CC=CC=C1 ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 description 5
- 238000010521 absorption reaction Methods 0.000 description 5
- 229940088598 enzyme Drugs 0.000 description 5
- 238000002360 preparation method Methods 0.000 description 5
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 5
- 239000008363 phosphate buffer Substances 0.000 description 3
- 239000000843 powder Substances 0.000 description 3
- 102000016938 Catalase Human genes 0.000 description 2
- 108010053835 Catalase Proteins 0.000 description 2
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 2
- PXIPVTKHYLBLMZ-UHFFFAOYSA-N Sodium azide Chemical compound [Na+].[N-]=[N+]=[N-] PXIPVTKHYLBLMZ-UHFFFAOYSA-N 0.000 description 2
- 239000000872 buffer Substances 0.000 description 2
- 230000006378 damage Effects 0.000 description 2
- 239000000376 reactant Substances 0.000 description 2
- 230000035484 reaction time Effects 0.000 description 2
- ALSTYHKOOCGGFT-KTKRTIGZSA-N (9Z)-octadecen-1-ol Chemical compound CCCCCCCC\C=C/CCCCCCCCO ALSTYHKOOCGGFT-KTKRTIGZSA-N 0.000 description 1
- CMCBDXRRFKYBDG-UHFFFAOYSA-N 1-dodecoxydodecane Chemical compound CCCCCCCCCCCCOCCCCCCCCCCCC CMCBDXRRFKYBDG-UHFFFAOYSA-N 0.000 description 1
- HAOXTAJLDMZCQJ-UHFFFAOYSA-N 1-ethoxydodecane Chemical compound CCCCCCCCCCCCOCC HAOXTAJLDMZCQJ-UHFFFAOYSA-N 0.000 description 1
- IEQAICDLOKRSRL-UHFFFAOYSA-N 2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-(2-dodecoxyethoxy)ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethanol Chemical compound CCCCCCCCCCCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCO IEQAICDLOKRSRL-UHFFFAOYSA-N 0.000 description 1
- ZAMOUSCENKQFHK-UHFFFAOYSA-N Chlorine atom Chemical compound [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 description 1
- 102000003992 Peroxidases Human genes 0.000 description 1
- 229920004890 Triton X-100 Polymers 0.000 description 1
- 208000027418 Wounds and injury Diseases 0.000 description 1
- 238000002835 absorbance Methods 0.000 description 1
- 230000008033 biological extinction Effects 0.000 description 1
- 239000000460 chlorine Substances 0.000 description 1
- 229910052801 chlorine Inorganic materials 0.000 description 1
- 238000005859 coupling reaction Methods 0.000 description 1
- 239000008367 deionised water Substances 0.000 description 1
- 229910021641 deionized water Inorganic materials 0.000 description 1
- 238000013461 design Methods 0.000 description 1
- 239000012153 distilled water Substances 0.000 description 1
- LQZZUXJYWNFBMV-UHFFFAOYSA-N dodecan-1-ol Chemical compound CCCCCCCCCCCCO LQZZUXJYWNFBMV-UHFFFAOYSA-N 0.000 description 1
- 230000002349 favourable effect Effects 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 238000007710 freezing Methods 0.000 description 1
- 230000008014 freezing Effects 0.000 description 1
- 231100001261 hazardous Toxicity 0.000 description 1
- WGCNASOHLSPBMP-UHFFFAOYSA-N hydroxyacetaldehyde Natural products OCC=O WGCNASOHLSPBMP-UHFFFAOYSA-N 0.000 description 1
- 229920013747 hydroxypolyethylene Polymers 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 208000014674 injury Diseases 0.000 description 1
- 239000002563 ionic surfactant Substances 0.000 description 1
- 230000002427 irreversible effect Effects 0.000 description 1
- 238000012792 lyophilization process Methods 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 229940055577 oleyl alcohol Drugs 0.000 description 1
- XMLQWXUVTXCDDL-UHFFFAOYSA-N oleyl alcohol Natural products CCCCCCC=CCCCCCCCCCCO XMLQWXUVTXCDDL-UHFFFAOYSA-N 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 230000003647 oxidation Effects 0.000 description 1
- 238000007254 oxidation reaction Methods 0.000 description 1
- 108040007629 peroxidase activity proteins Proteins 0.000 description 1
- 229960005222 phenazone Drugs 0.000 description 1
- 230000000241 respiratory effect Effects 0.000 description 1
- 210000002966 serum Anatomy 0.000 description 1
- 239000012064 sodium phosphate buffer Substances 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 125000004079 stearyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- 229940087291 tridecyl alcohol Drugs 0.000 description 1
- GPRLSGONYQIRFK-MNYXATJNSA-N triton Chemical compound [3H+] GPRLSGONYQIRFK-MNYXATJNSA-N 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/54—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving glucose or galactose
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S435/00—Chemistry: molecular biology and microbiology
- Y10S435/81—Packaged device or kit
Landscapes
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Analytical Chemistry (AREA)
- Emergency Medicine (AREA)
- Immunology (AREA)
- Microbiology (AREA)
- Molecular Biology (AREA)
- Biophysics (AREA)
- Physics & Mathematics (AREA)
- Biotechnology (AREA)
- Biochemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Investigating Or Analysing Biological Materials (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IT4760384 | 1984-01-27 | ||
| IT47603/84A IT1177513B (it) | 1984-01-27 | 1984-01-27 | Reattivo liquido pronto per l'uso per la determinazione del contenuto di glucosio nel sangue |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| NL8500181A true NL8500181A (nl) | 1985-08-16 |
Family
ID=11261370
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NL8500181A NL8500181A (nl) | 1984-01-27 | 1985-01-23 | Voor gebruik gereed vloeibaar reagens ter bepaling van het glucosegehalte in bloed. |
Country Status (12)
| Country | Link |
|---|---|
| US (1) | US5077199A (cs) |
| AT (1) | ATA20785A (cs) |
| BE (1) | BE901570A (cs) |
| CA (1) | CA1263934A (cs) |
| CH (1) | CH664160A5 (cs) |
| DE (1) | DE3502200A1 (cs) |
| ES (1) | ES8607554A1 (cs) |
| FR (1) | FR2558849B1 (cs) |
| GR (1) | GR850181B (cs) |
| IT (1) | IT1177513B (cs) |
| LU (1) | LU85734A1 (cs) |
| NL (1) | NL8500181A (cs) |
Families Citing this family (68)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE4207546A1 (de) * | 1992-03-10 | 1993-09-23 | Roland Man Druckmasch | Verfahren und vorrichtung zum ausrichten von druckplatten auf dem plattenzylinder von druckmaschinen, insbesondere bogenoffsetdruckmaschinen |
| EP0949336A1 (en) * | 1998-03-20 | 1999-10-13 | Unilever Plc | Process for identification of organic material |
| US6391005B1 (en) | 1998-03-30 | 2002-05-21 | Agilent Technologies, Inc. | Apparatus and method for penetration with shaft having a sensor for sensing penetration depth |
| US6540675B2 (en) | 2000-06-27 | 2003-04-01 | Rosedale Medical, Inc. | Analyte monitor |
| US8641644B2 (en) | 2000-11-21 | 2014-02-04 | Sanofi-Aventis Deutschland Gmbh | Blood testing apparatus having a rotatable cartridge with multiple lancing elements and testing means |
| WO2002061068A2 (en) * | 2001-01-31 | 2002-08-08 | Novozymes A/S | Oxidase free of catalase side activities |
| US7314453B2 (en) | 2001-05-14 | 2008-01-01 | Youti Kuo | Handheld diagnostic device with renewable biosensor |
| WO2002100254A2 (en) | 2001-06-12 | 2002-12-19 | Pelikan Technologies, Inc. | Method and apparatus for lancet launching device integrated onto a blood-sampling cartridge |
| US7025774B2 (en) | 2001-06-12 | 2006-04-11 | Pelikan Technologies, Inc. | Tissue penetration device |
| US7981056B2 (en) | 2002-04-19 | 2011-07-19 | Pelikan Technologies, Inc. | Methods and apparatus for lancet actuation |
| US9795747B2 (en) | 2010-06-02 | 2017-10-24 | Sanofi-Aventis Deutschland Gmbh | Methods and apparatus for lancet actuation |
| US7033371B2 (en) | 2001-06-12 | 2006-04-25 | Pelikan Technologies, Inc. | Electric lancet actuator |
| US8337419B2 (en) | 2002-04-19 | 2012-12-25 | Sanofi-Aventis Deutschland Gmbh | Tissue penetration device |
| US9427532B2 (en) | 2001-06-12 | 2016-08-30 | Sanofi-Aventis Deutschland Gmbh | Tissue penetration device |
| US9226699B2 (en) | 2002-04-19 | 2016-01-05 | Sanofi-Aventis Deutschland Gmbh | Body fluid sampling module with a continuous compression tissue interface surface |
| WO2002100251A2 (en) | 2001-06-12 | 2002-12-19 | Pelikan Technologies, Inc. | Self optimizing lancing device with adaptation means to temporal variations in cutaneous properties |
| US7344507B2 (en) | 2002-04-19 | 2008-03-18 | Pelikan Technologies, Inc. | Method and apparatus for lancet actuation |
| US7004928B2 (en) | 2002-02-08 | 2006-02-28 | Rosedale Medical, Inc. | Autonomous, ambulatory analyte monitor or drug delivery device |
| US7491178B2 (en) | 2002-04-19 | 2009-02-17 | Pelikan Technologies, Inc. | Method and apparatus for penetrating tissue |
| US7909778B2 (en) | 2002-04-19 | 2011-03-22 | Pelikan Technologies, Inc. | Method and apparatus for penetrating tissue |
| US7674232B2 (en) | 2002-04-19 | 2010-03-09 | Pelikan Technologies, Inc. | Method and apparatus for penetrating tissue |
| US8221334B2 (en) | 2002-04-19 | 2012-07-17 | Sanofi-Aventis Deutschland Gmbh | Method and apparatus for penetrating tissue |
| US7229458B2 (en) | 2002-04-19 | 2007-06-12 | Pelikan Technologies, Inc. | Method and apparatus for penetrating tissue |
| US7901362B2 (en) | 2002-04-19 | 2011-03-08 | Pelikan Technologies, Inc. | Method and apparatus for penetrating tissue |
| US9248267B2 (en) | 2002-04-19 | 2016-02-02 | Sanofi-Aventis Deustchland Gmbh | Tissue penetration device |
| US8784335B2 (en) | 2002-04-19 | 2014-07-22 | Sanofi-Aventis Deutschland Gmbh | Body fluid sampling device with a capacitive sensor |
| US7226461B2 (en) | 2002-04-19 | 2007-06-05 | Pelikan Technologies, Inc. | Method and apparatus for a multi-use body fluid sampling device with sterility barrier release |
| US7892183B2 (en) | 2002-04-19 | 2011-02-22 | Pelikan Technologies, Inc. | Method and apparatus for body fluid sampling and analyte sensing |
| US7232451B2 (en) | 2002-04-19 | 2007-06-19 | Pelikan Technologies, Inc. | Method and apparatus for penetrating tissue |
| US7297122B2 (en) | 2002-04-19 | 2007-11-20 | Pelikan Technologies, Inc. | Method and apparatus for penetrating tissue |
| US7892185B2 (en) | 2002-04-19 | 2011-02-22 | Pelikan Technologies, Inc. | Method and apparatus for body fluid sampling and analyte sensing |
| US9314194B2 (en) | 2002-04-19 | 2016-04-19 | Sanofi-Aventis Deutschland Gmbh | Tissue penetration device |
| US9795334B2 (en) | 2002-04-19 | 2017-10-24 | Sanofi-Aventis Deutschland Gmbh | Method and apparatus for penetrating tissue |
| US7331931B2 (en) | 2002-04-19 | 2008-02-19 | Pelikan Technologies, Inc. | Method and apparatus for penetrating tissue |
| US8579831B2 (en) | 2002-04-19 | 2013-11-12 | Sanofi-Aventis Deutschland Gmbh | Method and apparatus for penetrating tissue |
| US8267870B2 (en) | 2002-04-19 | 2012-09-18 | Sanofi-Aventis Deutschland Gmbh | Method and apparatus for body fluid sampling with hybrid actuation |
| US8702624B2 (en) | 2006-09-29 | 2014-04-22 | Sanofi-Aventis Deutschland Gmbh | Analyte measurement device with a single shot actuator |
| US8360992B2 (en) | 2002-04-19 | 2013-01-29 | Sanofi-Aventis Deutschland Gmbh | Method and apparatus for penetrating tissue |
| US7976476B2 (en) | 2002-04-19 | 2011-07-12 | Pelikan Technologies, Inc. | Device and method for variable speed lancet |
| US7547287B2 (en) | 2002-04-19 | 2009-06-16 | Pelikan Technologies, Inc. | Method and apparatus for penetrating tissue |
| US8574895B2 (en) | 2002-12-30 | 2013-11-05 | Sanofi-Aventis Deutschland Gmbh | Method and apparatus using optical techniques to measure analyte levels |
| US7052652B2 (en) | 2003-03-24 | 2006-05-30 | Rosedale Medical, Inc. | Analyte concentration detection devices and methods |
| US8262614B2 (en) | 2003-05-30 | 2012-09-11 | Pelikan Technologies, Inc. | Method and apparatus for fluid injection |
| DK1633235T3 (da) | 2003-06-06 | 2014-08-18 | Sanofi Aventis Deutschland | Apparat til udtagelse af legemsvæskeprøver og detektering af analyt |
| WO2006001797A1 (en) | 2004-06-14 | 2006-01-05 | Pelikan Technologies, Inc. | Low pain penetrating |
| EP1671096A4 (en) | 2003-09-29 | 2009-09-16 | Pelikan Technologies Inc | METHOD AND APPARATUS FOR PROVIDING IMPROVED SAMPLE CAPTURING DEVICE |
| WO2005037095A1 (en) | 2003-10-14 | 2005-04-28 | Pelikan Technologies, Inc. | Method and apparatus for a variable user interface |
| US7822454B1 (en) | 2005-01-03 | 2010-10-26 | Pelikan Technologies, Inc. | Fluid sampling device with improved analyte detecting member configuration |
| US8668656B2 (en) | 2003-12-31 | 2014-03-11 | Sanofi-Aventis Deutschland Gmbh | Method and apparatus for improving fluidic flow and sample capture |
| US8828203B2 (en) | 2004-05-20 | 2014-09-09 | Sanofi-Aventis Deutschland Gmbh | Printable hydrogels for biosensors |
| US9775553B2 (en) | 2004-06-03 | 2017-10-03 | Sanofi-Aventis Deutschland Gmbh | Method and apparatus for a fluid sampling device |
| US9820684B2 (en) | 2004-06-03 | 2017-11-21 | Sanofi-Aventis Deutschland Gmbh | Method and apparatus for a fluid sampling device |
| US8652831B2 (en) | 2004-12-30 | 2014-02-18 | Sanofi-Aventis Deutschland Gmbh | Method and apparatus for analyte measurement test time |
| US20060281187A1 (en) | 2005-06-13 | 2006-12-14 | Rosedale Medical, Inc. | Analyte detection devices and methods with hematocrit/volume correction and feedback control |
| CA2624117C (en) | 2005-09-30 | 2014-06-17 | Intuity Medical, Inc. | Fully integrated wearable or handheld monitor |
| US8801631B2 (en) | 2005-09-30 | 2014-08-12 | Intuity Medical, Inc. | Devices and methods for facilitating fluid transport |
| EP2265324B1 (en) | 2008-04-11 | 2015-01-28 | Sanofi-Aventis Deutschland GmbH | Integrated analyte measurement system |
| EP2293719B1 (en) | 2008-05-30 | 2015-09-09 | Intuity Medical, Inc. | Body fluid sampling device -- sampling site interface |
| EP2299904B1 (en) | 2008-06-06 | 2019-09-11 | Intuity Medical, Inc. | Medical measurement method |
| CA2726067C (en) | 2008-06-06 | 2020-10-20 | Intuity Medical, Inc. | Detection meter and mode of operation |
| US9375169B2 (en) | 2009-01-30 | 2016-06-28 | Sanofi-Aventis Deutschland Gmbh | Cam drive for managing disposable penetrating member actions with a single motor and motor and control system |
| WO2011065981A1 (en) | 2009-11-30 | 2011-06-03 | Intuity Medical, Inc. | Calibration material delivery devices and methods |
| US8965476B2 (en) | 2010-04-16 | 2015-02-24 | Sanofi-Aventis Deutschland Gmbh | Tissue penetration device |
| EP2584964B1 (en) | 2010-06-25 | 2021-08-04 | Intuity Medical, Inc. | Analyte monitoring devices |
| CN102141568B (zh) * | 2010-12-30 | 2013-12-04 | 北京九强生物技术股份有限公司 | 一种稳定的液体单试剂血糖试剂盒 |
| US9782114B2 (en) | 2011-08-03 | 2017-10-10 | Intuity Medical, Inc. | Devices and methods for body fluid sampling and analysis |
| CA2912283A1 (en) | 2013-06-21 | 2014-12-21 | Intuity Medical, Inc. | Analyte monitoring system with audible feedback |
| WO2023112442A1 (ja) * | 2021-12-13 | 2023-06-22 | テルモ株式会社 | 生体成分濃度測定試薬、測定方法およびセンサ |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3953295A (en) * | 1971-10-20 | 1976-04-27 | Mallinckrodt, Inc. | Reagent formulations for glucose assay |
| CA1104041A (en) * | 1977-02-03 | 1981-06-30 | Charles T. Goodhue | Hydrolysis of protein-bound cholesterol esters |
| US4340448A (en) * | 1978-08-28 | 1982-07-20 | University Of Pittsburgh | Potentiometric detection of hydrogen peroxide and apparatus therefor |
| EP0024578B1 (en) * | 1979-08-23 | 1983-12-07 | Ivan Endre Modrovich | Method of stabilizing an enzyme solution for use in total cholesterol determination, stabilized solution and test kit therefor |
| JPS5664789A (en) * | 1979-11-01 | 1981-06-02 | Toshiba Corp | Dried immobilized enzyme membrane and its preparation |
| US4540659A (en) * | 1981-04-17 | 1985-09-10 | Syva Company | Simultaneous calibration heterogeneous immunoassay |
| ATE8912T1 (de) * | 1980-07-10 | 1984-08-15 | Ivan Endre Modrovich | Stabilisierte enzymatische loesungen und verfahren zum bestimmen von gesamtcholesterin im menschlichen serum. |
| WO1983003254A1 (en) * | 1982-03-11 | 1983-09-29 | Arthur Babson | Stabilization of diazonium salt solutions |
| US4473638A (en) * | 1982-04-22 | 1984-09-25 | E. I. Du Pont De Nemours And Company | Specific binding assay |
-
1984
- 1984-01-27 IT IT47603/84A patent/IT1177513B/it active
-
1985
- 1985-01-03 US US06/688,587 patent/US5077199A/en not_active Expired - Fee Related
- 1985-01-08 CH CH63/85A patent/CH664160A5/it not_active IP Right Cessation
- 1985-01-09 CA CA000471777A patent/CA1263934A/en not_active Expired
- 1985-01-11 FR FR858500367A patent/FR2558849B1/fr not_active Expired
- 1985-01-15 ES ES539583A patent/ES8607554A1/es not_active Expired
- 1985-01-22 GR GR850181A patent/GR850181B/el unknown
- 1985-01-23 LU LU85734A patent/LU85734A1/fr unknown
- 1985-01-23 NL NL8500181A patent/NL8500181A/nl not_active Application Discontinuation
- 1985-01-24 DE DE19853502200 patent/DE3502200A1/de active Granted
- 1985-01-24 BE BE0/214391A patent/BE901570A/fr not_active IP Right Cessation
- 1985-01-25 AT AT0020785A patent/ATA20785A/de not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| FR2558849A1 (fr) | 1985-08-02 |
| DE3502200C2 (cs) | 1991-02-21 |
| BE901570A (fr) | 1985-05-17 |
| FR2558849B1 (fr) | 1989-07-07 |
| IT1177513B (it) | 1987-08-26 |
| ATA20785A (de) | 1993-08-15 |
| GR850181B (cs) | 1985-05-23 |
| ES8607554A1 (es) | 1986-05-16 |
| CH664160A5 (it) | 1988-02-15 |
| IT8447603A0 (it) | 1984-01-27 |
| DE3502200A1 (de) | 1985-08-08 |
| LU85734A1 (fr) | 1985-07-24 |
| ES539583A0 (es) | 1986-05-16 |
| CA1263934A (en) | 1989-12-19 |
| US5077199A (en) | 1991-12-31 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NL8500181A (nl) | Voor gebruik gereed vloeibaar reagens ter bepaling van het glucosegehalte in bloed. | |
| US4543326A (en) | Stabilization of oxidase | |
| US4517287A (en) | Method and reagent for the enzymatic determination of enzyme substrates | |
| Akimoto et al. | Luminol chemiluminescence reaction catalyzed by a microbial peroxidase | |
| US5288606A (en) | Reagent for specific determination of fructosamine | |
| US3721607A (en) | Reagent composition and process for the determination of glucose | |
| Mamoru et al. | A new colorimetric method for determination of serum glucose | |
| GB2154735A (en) | Reagent for determining blood glucose content | |
| Jørgensen et al. | An improved glucoseoxidase-peroxidase-coupled assay for β-fructofuranosidase activity | |
| EP0155427B1 (fr) | Nouveau milieu de culture, solide, à délitement rapide, prêt à l'emploi et procédé pour le préparer | |
| US5270194A (en) | Stabilized glucose oxidase from Aspergillus Niger | |
| EP0463755A1 (en) | Stable aqueous NADH reagent and kit | |
| JPH01108997A (ja) | 血液又は血液から導出した試料中の血清のフルクトスアミン含量を特異的に測定する方法及び試薬、及び非特異的還元作用を有するか、又は／及び溷濁を惹起する試料成分を除去する方法 | |
| JP4889396B2 (ja) | ロイコ色素の安定化方法 | |
| Majkić et al. | Determination of free and esterified cholesterol by a kinetic method: I. The introduction of the enzymatic method with 2, 2'-azino-di-3 [ethyl-benzthiazolin sulfonic acid (6)](ABTS) | |
| CA1079615A (en) | Composition for the enzymic determination of glucose | |
| JP2005278626A (ja) | 酵素的測定試薬の安定化方法 | |
| US4184921A (en) | Process and reagent for determining cholesterol | |
| JP4022799B2 (ja) | 電解質測定用試薬組成物 | |
| EP0418940B1 (en) | Stabilization of glucose oxidase enzyme in liquid reagent | |
| JP4013108B2 (ja) | リパーゼの安定化方法 | |
| JP2019176802A (ja) | ロイコ型色素の安定化方法 | |
| US20020009763A1 (en) | Reagent for GPT assay | |
| JPH0751095A (ja) | 生体成分測定試薬 | |
| US4722894A (en) | Method for the determination of ceruloplasmin activity |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| DNT | Communications of changes of names of applicants whose applications have been laid open to public inspection |
Free format text: MENARINI - INDUSTRIE FARMACEUTICHE RIUNITE |
|
| BA | A request for search or an international-type search has been filed | ||
| BB | A search report has been drawn up | ||
| BC | A request for examination has been filed | ||
| BV | The patent application has lapsed |